Showing results (951-960 of 6,154) with videos related to
Sort By:
Pageof 616
Nature Medicine|May 12, 2025
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trialPeter J Goadsby, Jessica Ailani, David W Dodick, et al.Nature Medicine|April 23, 2025
Comparative benchmarking of the DeepSeek large language model on medical tasks and clinical reasoningMickael Tordjman, Zelong Liu, Murat Yuce, et al.Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.Nature Medicine|May 1, 2025
Infant mental health services for birth and foster families of maltreated pre-school children in foster care (BeST?): a cluster-randomized phase 3 clinical effectiveness trialKaren Crawford, Robin Young, Philip Wilson, et al.Nature Medicine|April 21, 2025
Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trialJiang He, Chuansheng Zhao, Shanshan Zhong, et al.Nature Medicine|March 31, 2025
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's diseaseHamilton Se-Hwee Oh, Deniz Yagmur Urey, Linda Karlsson, et al.Nature Medicine|March 25, 2025
Optimal dietary patterns for healthy agingAnne-Julie Tessier, Fenglei Wang, Andres Ardisson Korat, et al.Nature Medicine|September 24, 2025
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trialGeorgina V Long, Nitya Nair, Daniel Marbach, et al.Nature Medicine|September 8, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analysesJoshua E Reuss, Paul K Lee, Reza J Mehran, et al.Nature Medicine|August 13, 2025
Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trialUlrik N Jeppesen, Ditte L Vernal, Anne Sofie Due, et al.Pageof 616